Ozempic Cost Without Insurance: The Ladder Behind the $199

Before the prices: Ozempic is approved to improve blood sugar in adults with type 2 diabetes, not for weight loss². The same molecule — semaglutide — is sold as Wegovy for weight management. If weight is why you are here, Wegovy is the approved product and its own price ladder is here. People are prescribed Ozempic off-label for weight, which is a decision for you and a clinician, not a pricing question. What follows is what it costs.

Every figure below is quoted from Novo Nordisk's published savings terms¹, read in August 2026.

The self-pay ladder

The terms are specific: "Patients new to the Ozempic Savings Offer or NovoCare Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg. Offer for 2 monthly fills through December 31, 2026, then $349 per month for Ozempic 0.25 mg, 0.5 mg, or 1 mg, and $499/month for Ozempic 2 mg."

So the pen ladder is:

- **0.25 mg and 0.5 mg — $199**, for two fills, through December 31, 2026 - **0.25, 0.5 and 1 mg — $349** after that - **2 mg — $499**

There is also an Ozempic pill, listed separately at **"starting at $149 per month"** for the 1.5 mg dose.

The shape is the same one Wegovy uses: the advertised number is real, it covers two fills at the doses you start on, and it has an expiry date on it. The figure that describes staying on the medicine is $349 — or $499 if you end up at 2 mg.

"One month" is one pen

Novo defines a month here as "1 box of 1 Ozempic pen and 1 bottle of 30 tablets of Ozempic pill." An Ozempic pen is a 28-day supply at most doses, so a year is closer to thirteen fills than twelve. That is the same arithmetic we apply to every telehealth program we track — a "/mo" is not a calendar month until you know the billing cycle.

The insured price, and who is shut out of it

With commercial insurance the offer is "as little as $25 per month for up to 3 months," subject to "a max savings of $100/month."

Two limits worth reading twice. The card runs **up to three months**, not indefinitely. And **"Government beneficiaries excluded"** — so Medicare, Medicaid and similar are out. Novo does carve out an exception worth knowing: the terms state that the Federal Employees Health Benefits Program, Affordable Care Act exchange plans, and state employee plans "are NOT federal or state government health care programs for purposes of this savings offer," which means those patients are not excluded.

If you have commercial coverage that pays for Ozempic, that route almost always beats the cash prices above — but check what happens in month four. More on that in do GLP-1 savings cards actually lower the price?

Comparing it to a cash compounded program

Across the 364 programs we track that publish a semaglutide price (counted August 2026), the median is about $180 a month and the lower quartile is $149. The cheapest publishing a genuinely flat, month-to-month rate runs $93. The sorted spread is on the cheapest semaglutide ranking.

Against $349, that is a wide gap, and it comes with the same two caveats we put on every brand-versus-compounded comparison:

- Ozempic is an FDA-approved finished medicine. Compounded semaglutide is not FDA-approved and is not reviewed for safety, effectiveness or quality³. - Compounded sellers run their own version of the two-fill trick — starting-dose rates, plan terms, fees billed beside the drug. We flag those per program, and the argument in full is in compounded versus brand-name GLP-1 cost.

The short version

$199 is two fills at the starting doses, through December 31, 2026. Then it is $349, or $499 at 2 mg, and $149 if you are on the pill. Budget against the number that applies in month three, not month one — and if weight is the goal, price Wegovy and Zepbound too, since those carry the weight-management approvals.

More in our research index.